EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME AT ONE YEAR

被引：0
|
作者：
Berenbaum, F. [1 ]
Pham, T. [2 ]
Fautrel, B. [3 ]
Joubert, J. M. [4 ]
De Chalus, T. [4 ]
Franca, Riou L. [5 ]
Claudepierre, P. [6 ]
机构：
[1] CHU St Antoine, Paris, France
[2] CHU St Marguerite, Marseille, France
[3] CHU Pitie Salpetriere, Paris, France
[4] UCB Pharma, Colombes, France
[5] Phisquare Inst, Paris, France
[6] Grp Hosp Henri Mondor, Creteil, France
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1452
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A556 / A556
页数：1
相关论文
共 50 条
  • [21] A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
    Weinblatt, Michael E.
    Bingham, Clifton O., III
    Burmester, Gerd-Ruediger
    Bykerk, Vivian P.
    Furst, Daniel E.
    Mariette, Xavier
    van der Heijde, Desiree
    van Vollenhoven, Ronald
    VanLunen, Brenda
    Ecoffet, Cecile
    Cioffi, Christopher
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (10) : 1937 - 1948
  • [22] Certolizumab pegol: a new biologic targeting rheumatoid arthritis
    Patel, Aarat M.
    Moreland, Larry W.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 855 - 866
  • [23] The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
    Fleischmann, Roy
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (05) : 773 - 786
  • [24] Long-Term Maintenance of Response in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol
    Saraux, Alain
    Flipo, Rene-Marc
    Fagnani, Francis
    Cukierman, Gabrielle
    Bru, Isabelle
    Joubert, Jean-Michel
    Schuller, Jan-Christof
    Massol, Jacques
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS
    Carlino, G.
    Cozzolongo, A.
    Maggio, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1049 - 1049
  • [26] Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
    Ruiz Garcia, Vicente
    Jobanputra, Paresh
    Burls, Amanda
    Cabello, Juan B.
    Vela Casasempere, Paloma
    Bort-Marti, Sylvia
    Kynaston-Pearson, Francis J. B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [27] Functional MRI shows a faster Response of Certolizumab-Pegol in Patients with Rheumatoid Arthritis
    Rech, J.
    Finzel, S.
    Kreitz, S.
    Englbrecht, M.
    Sergeeva, M.
    Roesch, J.
    Doerfler, A.
    Hess, A.
    Schett, G.
    INTERNIST, 2013, 54 : 55 - 55
  • [28] SYNOVIAL LYMPHOCYTIC AGGREGATES PREDICT CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS (CLINICAL AND PATHOLOGICAL RESPONSE TO CERTOLIZUMAB-PEGOL (CLIP-CERT) STUDY)
    Di Cicco, M.
    Kelly, S.
    Humby, F.
    Ng, N.
    Nerviani, A.
    Rocher, V.
    Hands, R.
    Bombardieri, M.
    Pitzalis, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 606 - 607
  • [29] CHILD OUTCOME AFTER CERTOLIZUMAB PEGOL EXPOSURE IN RHEUMATOID ARTHRITIS PREGNANCIES: A CASE SERIES REPORT
    Meroni, M.
    Ramoni, V. L.
    Brucato, A. L.
    Limonta, M.
    Ostensen, M.
    Cutolo, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 711 - 711
  • [30] CERTOLIZUMAB PEGOL EXPOSURE IN RHEUMATOID ARTHRITIS PREGNANCIES: A CASE SERIES
    Meroni, M.
    Pizzorni, C.
    Paolino, S.
    Gerbaldo, D.
    Gustavino, C.
    Seriolo, B.
    Cutolo, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 990 - 990
12345